Table 2.
IBS common criteria. Seven criteria were employed to assess formulation efficacy; criteria match the symptoms of IBS. This table shows the measurement used for each criterion, the score, and the evaluation type (related to the MCDA method).
| Criterium | Criterium Title | Measurement | Score Type | Evaluation Type |
|---|---|---|---|---|
| C1 | Bloating | % Value of the improvement | VAS (0–10) | Maximization |
| C2 | Pain | % Value of the improvement | VAS (0–10) | Maximization |
| C3 | Cramps | % Value of the improvement | VAS (0–10) | Maximization |
| C4 | Flatulence | % Value of the improvement | VAS (0–10) | Maximization |
| C5 | Constipation | % Value of the improvement | VAS (0–10) | Maximization |
| C6 | Quality Life | % Value of the improvement | Q-score (100–300) | Maximization |
| C7 | Efficacy | Number of trials resulting not effective | Yes/No | Minimized |